| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.3 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |